Literature DB >> 26160743

The Decline of Pertussis-Specific Antibodies After Tetanus, Diphtheria, and Acellular Pertussis Immunization in Late Pregnancy.

Bahaa Abu Raya1, Isaac Srugo2, Aharon Kessel3, Michael Peterman4, Avraham Vaknin5, Ellen Bamberger6.   

Abstract

We prospectively measured pertussis-specific antibodies 9-15 months after delivery in women immunized with tetanus, diphtheria, and acellular pertussis (Tdap) after the 20th week of their recent pregnancy. The Tdap-immunized women (n = 38) exhibited a decline in geometric mean concentrations between their peripartum and follow-up levels for immunoglobulin G to pertussis toxin (21.48 [95% confidence interval, 12.51-36.89] vs 11.72 [7.09-19.37] IU/mL];); filamentous hemagglutinin (185.95 [157.93-218.94] vs 140.33 IU/mL [113.46-173.57] IU/mL); and pertactin (171.52 [120.73-243.67] vs 83.74 [60.58-115.75] IU/mL) (all P < .001). For women immunized with Tdap during late pregnancy, pertussis-specific immunoglobulin G levels decreased significantly 9-15 months after delivery.
© The Author 2015. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  immunoglobulin G; maternal immunization; pertussis; pertussis toxin; tetanus-diphtheria-acellular pertussis

Mesh:

Substances:

Year:  2015        PMID: 26160743     DOI: 10.1093/infdis/jiv324

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  9 in total

Review 1.  What to do about pertussis vaccines? Linking what we know about pertussis vaccine effectiveness, immunology and disease transmission to create a better vaccine.

Authors:  Shelly Bolotin; Eric T Harvill; Natasha S Crowcroft
Journal:  Pathog Dis       Date:  2015-08-06       Impact factor: 3.166

Review 2.  Immune persistence after pertussis vaccination.

Authors:  Zhiyun Chen; Qiushui He
Journal:  Hum Vaccin Immunother       Date:  2017-01-03       Impact factor: 3.452

3.  Pertussis vaccination in pregnancy in Canada: a cost-utility analysis.

Authors:  Bahaa Abu-Raya; Doug Coyle; Julie A Bettinger; Wendy Vaudry; Scott A Halperin; Manish Sadarangani
Journal:  CMAJ Open       Date:  2020-10-19

4.  Decay of anti-Bordetella pertussis antibodies in women of childbearing age following COVID-19 non-pharmaceutical measures.

Authors:  Frederic Reicherz; Liam Golding; Pascal M Lavoie; Bahaa Abu-Raya
Journal:  Vaccine       Date:  2022-05-11       Impact factor: 4.169

Review 5.  Vaccination during pregnancy: current and possible future recommendations.

Authors:  Kirsten Maertens; Marjolein Rozemarie Paulien Orije; Pierre Van Damme; Elke Leuridan
Journal:  Eur J Pediatr       Date:  2020-01-07       Impact factor: 3.183

6.  The Effect of Timing of Tetanus-Diphtheria-Acellular Pertussis Vaccine Administration in Pregnancy on the Avidity of Pertussis Antibodies.

Authors:  Bahaa Abu-Raya; Michelle L Giles; Tobias R Kollmann; Manish Sadarangani
Journal:  Front Immunol       Date:  2019-10-11       Impact factor: 7.561

Review 7.  Immunological and Clinical Benefits of Maternal Immunization Against Pertussis: A Systematic Review.

Authors:  Charlotte Switzer; Caroline D'Heilly; Denis Macina
Journal:  Infect Dis Ther       Date:  2019-09-18

Review 8.  Pertactin-Deficient Bordetella pertussis, Vaccine-Driven Evolution, and Reemergence of Pertussis.

Authors:  Longhuan Ma; Amanda Caulfield; Kalyan K Dewan; Eric T Harvill
Journal:  Emerg Infect Dis       Date:  2021-06       Impact factor: 6.883

Review 9.  Global Perspectives on Immunization During Pregnancy and Priorities for Future Research and Development: An International Consensus Statement.

Authors:  Bahaa Abu-Raya; Kirsten Maertens; Kathryn M Edwards; Saad B Omer; Janet A Englund; Katie L Flanagan; Matthew D Snape; Gayatri Amirthalingam; Elke Leuridan; Pierre Van Damme; Vana Papaevangelou; Odile Launay; Ron Dagan; Magda Campins; Anna Franca Cavaliere; Tiziana Frusca; Sofia Guidi; Miguel O'Ryan; Ulrich Heininger; Tina Tan; Ahmed R Alsuwaidi; Marco A Safadi; Luz M Vilca; Nasamon Wanlapakorn; Shabir A Madhi; Michelle L Giles; Roman Prymula; Shamez Ladhani; Federico Martinón-Torres; Litjen Tan; Lessandra Michelin; Giovanni Scambia; Nicola Principi; Susanna Esposito
Journal:  Front Immunol       Date:  2020-06-24       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.